Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA

Access the “What This Means” segment hereCAMBRIDGE, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry ...
STAT

The FDA’s absence from international standards meetings threatens U.S. leadership

When U.S. regulators aren’t in the room while global standards are written, the future of patient safety, medical innovation, and cybersecurity are at risk. For decades, the Food and Drug ...
JD Supra

FDA PreCheck meeting weighs how more clarity may help de-risk US manufacturing investments - Agency invites additional comments on PreCheck in public docket

At a September 30, 2025, public meeting hosted by the U.S. Food and Drug Administration (FDA), industry stakeholders expressed strong support for the newly launched FDA PreCheck Program, while raising ...
Seeking Alpha

Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting

GLEN ALLEN, Va., June 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...